X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
index medicus (26) 26
oncology (16) 16
animals (15) 15
cell line, tumor (15) 15
mice (13) 13
apoptosis - drug effects (8) 8
male (8) 8
hematology (7) 7
research (7) 7
expression (6) 6
female (6) 6
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (6) 6
lysine - analogs & derivatives (6) 6
medicine (6) 6
mixed function oxygenases - metabolism (6) 6
oxidoreductases acting on ch-nh group donors - metabolism (6) 6
phosphorylation (6) 6
protein kinase inhibitors - therapeutic use (6) 6
proteins (6) 6
apoptosis (5) 5
blotting, western (5) 5
cancer (5) 5
cell proliferation (5) 5
cell proliferation - drug effects (5) 5
cellular senescence (5) 5
chronic myeloid-leukemia (5) 5
dna-binding proteins - metabolism (5) 5
leukemia (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - pathology (5) 5
multidisciplinary sciences (5) 5
tumor suppressor protein p53 - metabolism (5) 5
610 medicine & health (4) 4
biology (4) 4
cancer-cells (4) 4
chronic myelogenous leukemia (4) 4
chronic myeloid leukemia (4) 4
clinic for hematology (4) 4
disease models, animal (4) 4
drug resistance (4) 4
enzyme inhibitors - pharmacology (4) 4
gene expression regulation, neoplastic (4) 4
gene expression regulation, neoplastic - drug effects (4) 4
growth (4) 4
imatinib mesylate (4) 4
kinases (4) 4
lysine - metabolism (4) 4
peptide initiation factors - metabolism (4) 4
protein kinase inhibitors - pharmacology (4) 4
proteomics (4) 4
research article (4) 4
transcription, genetic (4) 4
tumors (4) 4
aged (3) 3
analysis (3) 3
aurora kinases (3) 3
benzamides - pharmacology (3) 3
benzamides - therapeutic use (3) 3
biochemistry & molecular biology (3) 3
bone marrow (3) 3
breast cancer (3) 3
breast neoplasms - metabolism (3) 3
cell-proliferation (3) 3
cellular senescence - drug effects (3) 3
children (3) 3
development and progression (3) 3
disease progression (3) 3
down-regulation (3) 3
drug resistance, neoplasm - drug effects (3) 3
gene (3) 3
gene knockdown techniques (3) 3
gene-expression (3) 3
genetic aspects (3) 3
glioblastoma - pathology (3) 3
growth-factor (3) 3
hematology, oncology and palliative medicine (3) 3
hemic and lymphatic diseases (3) 3
imatinib (3) 3
in-vivo (3) 3
inhibition (3) 3
initiation-factor 5a (3) 3
length (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - enzymology (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - genetics (3) 3
lymphomas (3) 3
mice, inbred nod (3) 3
mice, scid (3) 3
mixed function oxygenases - genetics (3) 3
molecular targeted therapy (3) 3
mutation (3) 3
neoplasm proteins - metabolism (3) 3
oligonucleotide array sequence analysis (3) 3
oncogenic activity (3) 3
oxidoreductases acting on ch-nh group donors - antagonists & inhibitors (3) 3
oxidoreductases acting on ch-nh group donors - genetics (3) 3
peptide initiation factors - genetics (3) 3
pharmacology (3) 3
piperazines - pharmacology (3) 3
piperazines - therapeutic use (3) 3
proliferation (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 08/2005, Volume 436, Issue 7051, pp. 660 - 665
Journal Article
Molecular Cancer, ISSN 1476-4598, 10/2011, Volume 10, Issue 1, pp. 129 - 129
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2018, Volume 118, Issue 1, pp. 43 - 51
Background: Although altered membrane physiology has been discussed within the context of cancer, targeting membrane characteristics by drugs being an... 
proliferation | metastasis | soraphen A | cancer | metabolism | acetyl-CoA carboxylase | tumour growth | membrane characteristics | CHEMICAL INHIBITION | FATTY-ACID SYNTHESIS | PROTECTS | CELL LUNG-CANCER | ONCOLOGY | GROWTH | MEMBRANE-LIPID THERAPY | MODULATION | Fatty Acid Synthase, Type I - genetics | Neoplasms - metabolism | Cell Proliferation | Humans | Phospholipids - analysis | Molecular Targeted Therapy | Acetyl-CoA Carboxylase - genetics | Gene Knockdown Techniques | Enzyme Inhibitors - administration & dosage | Cerulenin - pharmacology | Macrolides - pharmacology | Acetyl-CoA Carboxylase - antagonists & inhibitors | Cell Membrane - drug effects | Photobleaching | Macrolides - administration & dosage | Neoplasm Invasiveness | Enzyme Inhibitors - pharmacology | Cerulenin - administration & dosage | Fatty Acid Synthase, Type I - antagonists & inhibitors | Membrane Fluidity - drug effects | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Lipogenesis - drug effects | Cell Line, Tumor | Membranes | Deformability | Deformation | Fluorescence | Confocal microscopy | Immunoblotting | Phospholipids | Drug delivery | Confocal | Composition effects | Metastases | Anticancer properties | Receptors | Fluidity | Fluorescence recovery after photobleaching | Acetyl-CoA carboxylase | Cascades | Cerulenin | Lipogenesis | Membrane vesicles | Formability | Phospholipid composition | Fatty acids | Fatty-acid synthase | Signaling | Microscopy | In vivo methods and tests | Scanning microscopy | Cancer | Tumors | Index Medicus | Translational Therapeutics
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2015, Volume 290, Issue 30, pp. 18343 - 18360
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 4, pp. e19164 - e19164
The success of Imatinib (IM) therapy in chronic myeloid leukemia (CML) is compromised by the development of IM resistance and by a limited IM effect on... 
CHRONIC MYELOGENOUS LEUKEMIA | PRIMARY CML | CD34(+) CELLS | STEM-CELLS | THERAPY | AURORA KINASES | MULTIDISCIPLINARY SCIENCES | CLINICAL RESISTANCE | IMATINIB MESYLATE | HEMATOPOIETIC PROGENITORS | CHRONIC MYELOID-LEUKEMIA | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Oligonucleotide Array Sequence Analysis | Apoptosis - drug effects | Humans | Hematopoietic Stem Cells - pathology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | ATP-Binding Cassette Transporters - genetics | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Protein-Serine-Threonine Kinases - antagonists & inhibitors | ATP-Binding Cassette Transporters - metabolism | Benzamides - pharmacology | Clone Cells | Neoplasm Proteins - genetics | Protein-Serine-Threonine Kinases - metabolism | Pyrazoles - pharmacology | Hematopoietic Stem Cells - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Polyploidy | Gene Expression Regulation, Leukemic - drug effects | Aurora Kinases | Pyrimidines - pharmacology | Mutation - genetics | Imatinib Mesylate | Piperazines - pharmacology | Drug Synergism | Drug Resistance, Neoplasm - genetics | Signal Transduction - drug effects | Cell Differentiation - drug effects | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Fusion Proteins, bcr-abl - metabolism | ATP-Binding Cassette Transporters - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | BCR protein | Phosphorylation | Low concentrations | Leukemia | Oncology | Aurora kinase | Drug resistance | Kinases | Signal transduction | Emergence | Inhibition | Fusion protein | Efflux | Imatinib | Myeloid leukemia | Abl protein | Breast cancer | Chronic myeloid leukemia | Disease control | Signaling | Inhibitors | Stem cells | Proteomics | Lymphomas | Combined treatment | Mutation | Transporter | Apoptosis | Index Medicus
Journal Article
Neoplasia, ISSN 1476-5586, 09/2009, Volume 11, Issue 9, pp. 934 - 944
Journal Article
Journal Article
Nature, ISSN 0028-0836, 05/2011, Volume 473, Issue 7347, pp. 384 - 391
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 10/2011, Volume 208, Issue 11, pp. 2163 - 2174
Journal Article
Journal Article